Fourth Chinese National Consensus Report on the management of Helicobacter pylori infection (Q38072783)

28 August 2017

Fourth Chinese National Consensus Report on the management of Helicobacter pylori infection (English)

1 reference

Helicobacter pylori infectious disease

28 August 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Chinese Society of Gastroenterology, Chinese Study Group on Helicobacter pylori

1

1 reference

28 August 2017

Wen Zhong Liu

2

1 reference

28 August 2017

Yong Xie

3

1 reference

28 August 2017

Hong Cheng

4

1 reference

28 August 2017

Nong Hua Lu

5

1 reference

28 August 2017

Fu Lian Hu

6

1 reference

28 August 2017

Wan Dai Zhang

7

1 reference

28 August 2017

Li Ya Zhou

8

1 reference

28 August 2017

Ye Chen

9

1 reference

28 August 2017

Zhi Rong Zeng

10

1 reference

28 August 2017

Chong Wen Wang

11

1 reference

28 August 2017

Shu Dong Xiao

12

1 reference

28 August 2017

Guo Zong Pan

13

1 reference

28 August 2017

Pin Jin Hu

14

1 reference

28 August 2017

1 May 2013

1 reference

Journal of Digestive Diseases

28 August 2017

1 reference

28 August 2017

14

1 reference

28 August 2017

211-221

1 reference

28 August 2017

5

1 reference

Barry Marshall 2005 Nobel laureate in medicine and physiology.

28 August 2017

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12034

Review article: common misconceptions in the management of Helicobacter pylori-associated gastric MALT-lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12034

Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12034

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12034

Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12034

Systematic review and meta-analysis from Chinese literature: the association between Helicobacter pylori eradication and improvement of functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12034

American gastroenterological association technical review on the evaluation of dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12034

Carcinogenesis of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12034

Consensus on chronic gastritis in China--Second National Consensus Meeting on Chronic Gastritis (14-16 September 2006 Shanghai, China).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12034

The long-term impact of Helicobacter pylori eradication on gastric histology: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12034

Gastric atrophy and intestinal metaplasia before and after Helicobacter pylori eradication: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12034

Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12034

Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12034

Long-term proton pump inhibitor administration worsens atrophic corpus gastritis and promotes adenocarcinoma development in Mongolian gerbils infected with Helicobacter pylori.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12034

Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12034

Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12034

Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12034

Iron deficiency anemia in Helicobacter pylori infection: meta-analysis of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12034

Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12034

Healing of lymphocytic gastritis after Helicobacter pylori eradication therapy--a randomized, double-blind, placebo-controlled multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12034

Effect of drug treatment on hyperplastic gastric polyps infected with Helicobacter pylori: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12034

Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12034

Helicobacter pylori "test-and-treat" strategy is not suitable for the management of patients with uninvestigated dyspepsia in Shanghai

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12034

Effect of Helicobacter pylori treatment on gastroesophageal reflux disease (GERD): meta-analysis of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12034

Effects of Helicobacter pylori eradication on gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12034

Effect of Helicobacter pylori infection and its eradication on reflux esophagitis and reflux symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12034

Detection of Helicobacter pylori and determination of clarithromycin susceptibility using formalin-fixed, paraffin-embedded gastric biopsy specimens by fluorescence in situ hybridization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12034

Review article: 13C-urea breath test in the diagnosis of Helicobacter pylori infection -- a critical review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12034

Diagnostic performance of urea breath test, rapid urea test, and histology for Helicobacter pylori infection in patients with partial gastrectomy: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12034

Resistance of Helicobacter pylori to antibiotics from 2000 to 2009 in Shanghai

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12034

Helicobacter pylori detection and antimicrobial susceptibility testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12034

Comparison of the efficacy of triple versus quadruple therapy on the eradication of Helicobacter pylori and antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12034

Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12034

The challenge of Helicobacter pylori resistance to antibiotics: the comeback of bismuth-based quadruple therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12034

Adverse events with bismuth salts for Helicobacter pylori eradication: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12034

Meta-analysis: the efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12034

High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12034

A randomized controlled trial: efficacy and safety of azithromycin, ofloxacin, bismuth, and omeprazole compared with amoxicillin, clarithromycin, bismuth, and omeprazole as second-line therapy in patients with Helicobacter pylori infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12034

Esomeprazole versus omeprazole for the eradication of Helicobacter pylori infection: results of a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12034

21 January 2018

Identifiers

DOI

10.1111/1751-2980.12034

1 reference

28 August 2017

1 reference